02359 WUXI APPTEC
- 36.750
- +1.550+4.40%
WUXI APPTEC News
藥明康德：2023年度報告
On April 26, Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 475,500 A shares
Gelonghui, April 26, 丨 Yao Ming Kangde (02359.HK) issued an announcement. On April 26, 2024, it spent RMB 2005 million yuan to buy back 475,500 A shares, with a repurchase price of 41.32-43.11 yuan per share.
Yao Ming Kangde (02359) spent 2.047,800 yuan to buy back 475,500 A shares on April 26
Yao Ming Kangde (02359) announced that on April 26, 2024, the company spent 2.047,800 yuan to buy back 475,500 A-shares.
Trending Industry Today: TIGERMED Leads Gains In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 26th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending higher today with 8 constituents up and TIGERMED leading Gains.$TIGERMED(03
Changes in Hong Kong stocks | Tiger Pharmaceuticals (03347) rose more than 8% to lead CRO concept stocks, reports say the national level is expected to introduce an action plan for the biological manufacturing industry in the near future
CRO concept stocks increased their gains in the afternoon. As of press release, Tiger Pharmaceuticals (03347) rose 8.39% to HK$33.6; Kanglong Chemical (03759) rose 7.16% to HK$9.43; Pharmaceutical Biotech (02269) rose 6.75% to HK$13.6; and Pharmaceuticals (02359) rose 4.74% to HK$35.35.
Will Weakness in WuXi AppTec Co., Ltd.'s (SHSE:603259) Stock Prove Temporary Given Strong Fundamentals?
WuXi AppTec (SHSE:603259) has had a rough three months with its share price down 37%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually d
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 479,000 A shares on April 25
On April 25, Ge Longhui | Yao Ming Kangde (02359.HK) issued an announcement. On April 25, 2024, it spent RMB 2005 million yuan to repurchase 479,000 A shares, with a repurchase price of 41.6-42.39 yuan per share.
Yao Ming Kangde (02359) spent 2.046,800 yuan to buy back 475,800 A shares on April 24
Yao Ming Kangde (02359) issued an announcement to repurchase 475,800 A-shares with RMB 2.046,800 on April 24, 2024.
Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to Research
Yao Ming Kangde (02359) spent about 2.048,000 yuan to buy back 475,700 A shares on April 23
Yao Ming Kangde (02359) announced that on April 23, 2024, it cost about 2.048,000 yuan to buy back 47.5...
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 474,200 A shares on April 19
On April 19, Ge Longhui (02359.HK) issued an announcement. On April 19, 2024, it spent RMB 2005 million yuan to buy back 474,200 A shares, with a repurchase price of 41.88-42.9 yuan per share.
Trending Industry Today: GENSCRIPT BIO Leads Losses In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 19th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending lower today with 9 constituents down and GENSCRIPT BIO leading Losses.$GENS
Changes in Hong Kong stocks | CRO concept stocks continue to decline, the Federal Reserve does not rule out possible interest rate hikes, domestic innovative drugs are still in an adjustment cycle
The Zhitong Finance App learned that CRO concept stocks continued to decline. As of press release, Tiger Pharmaceuticals (03347) fell 7.94% to HK$28.4; Kingsley Biotech (01548) fell 5.93% to HK$10.78; Kanglong Chemical (03759) fell 4.83% to HK$8.47; and Pharmaceuticals (02359) fell 4.5% to HK$32.9. According to the news, overnight, Federal Reserve officials made hawkish remarks. New York Federal Reserve Chairman Williams said that if the data reminds us that we need to raise interest rates to achieve our goals, then we will obviously do it. Furthermore, Asia
Yao Ming Kangde (02359) spent 2.047,900 yuan to buy back 458,600 A shares on April 18
Yao Ming Kangde (02359) announced that on April 18, 2024, the company spent RMB 2004...
Yao Ming Kangde (02359) spent 20048,200 yuan to buy back 477,400 A shares on April 17
Yao Ming Kangde (02359) announced that on April 17, 2024, the company spent RMB 2004...
Changes in Hong Kong stocks | Yao Ming Kangde (02359) AH shares rose more than 5% in the short term and recently received J.P. Morgan Chase's holdings increased by about 560,000 shares
Yao Ming Kangde (02359) AH shares rose more than 5% in the short term. As of press release, H shares rose 5.03% to HK$34.45, with a turnover of HK$143 million.
Yao Ming Kangde (02359.HK) received 559,300 shares from J.P. Morgan
Glonghui, April 17 | According to the latest equity disclosure data on the Stock Exchange, on April 11, 2024, Yao Ming Kangde (02359.HK) obtained JPMorgan Chase & Co. to increase its position by 559,300 shares at an average price of HK$35.4316 per share, involving an investment of approximately HK$19816 million. After the increase in holdings, JPMorgan Chase & Co.'s latest number of open positions was 35.95,500 shares, and the holding ratio increased from 8.92% to 9.06%.
Yao Ming Kangde (02359) spent about 2.0492 million yuan to buy back 485,500 A shares on April 16
Yao Ming Kang De (02359) issued an announcement and spent about 2.0492 million yuan on April 16, 2024 (people...
Changes in Hong Kong stocks | Zhaoyan Pharmaceutical (06127) fell more than 6%, leading the CRO concept, the possibility that the Federal Reserve will raise interest rates is still possible, and domestic innovative drugs are still in the adjustment cycle
CRO concept stocks continued to decline. As of press release, Zhaoyan Pharmaceutical (06127) fell 5.98% to HK$9.28; Tiger Pharmaceuticals (03347) fell 5.93% to HK$30.15; Kanglong Chemical (03759) fell 5.18% to HK$8.78; and Pharmaceuticals (02359) fell 3.96% to HK$32.75.
Yao Ming Kangde (02359.HK) held a board meeting on April 29 to consider and approve the first quarter results
Gelonghui, April 15, 丨 Yao Ming Kangde (02359.HK) announced that it will hold a board meeting on April 29, 2024 (Monday) to consider and approve (including) the Group's first quarter results for the three months ended March 31, 2024 and their release.
Analysis
Price Target
No Data
